Jaguar Health Inc. (JAGX) Stock Forecast & Analysis

Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for Jaguar Health Inc. (JAGX:NASDAQ), powered by AI.

Current Price
$2.31
P/E Ratio
-0.1
Market Cap
5M
Sector
Healthcare
What is the Jaguar Health Inc. stock price forecast?

Jaguar Health Inc. is currently trading at $2.31. View real-time AI analysis on Alpha Lenz.

What is Jaguar Health Inc. insider trading activity?

View the latest insider trading data for Jaguar Health Inc. on Alpha Lenz.

What is Jaguar Health Inc.'s P/E ratio?

Jaguar Health Inc.'s P/E ratio is -0.1.

Jaguar Health Inc.

NASDAQ · JAGX
$2.31-0.16(-6.48%)Pre-marketNASDAQ regular session 09:30–16:00 ET
Ask about Jaguar Health Inc.'s future dividend policy...
Alpha Chat Insight

Jaguar Health Inc. trades at a P/E of -0.1 (undervalued) with strong ROE of 1068.3%.

Ask for details

Company Overview

Jaguar Health Inc. is a commercial-stage pharmaceuticals and biotechnology company that focuses on the development and commercialization of novel plant-based prescription medicines. The primary purpose of Jaguar Health is to address health issues in both humans and animals, thereby playing a crucial role in the biopharmaceutical industry. Known for its commitment to improving global health standards, Jaguar Health emphasizes the development of effective digestive health medications, often derived from naturally occurring sources. The company is particularly noted for its work in creating treatments aimed at chronic, debilitating conditions such as diarrhea in human populations, including those in resource-constrained settings. Jaguar Health's subsidiaries and collaborations allow it to expand its reach and impact across various markets, emphasizing innovation within the realms of botanical sciences and pharmaceuticals. In the financial market, Jaguar Health Inc. garners attention for its unique position at the intersection of natural medicine and pharmaceutical technology, appealing to investors interested in both health innovation and sustainable medicinal approaches. As such, Jaguar Health holds a distinctive role within the global healthcare sector.

CEOMs. Lisa A. Conte
SectorHealthcare
IndustryBiotechnology
Employees49

Company Statistics

FY 2025

Profile

$5.39MMarket Cap
$11.51MRevenue
0.00Shares Out
49Employees

Margins

67.21%Gross
-372.37%EBITDA
-391.87%Operating
-469.09%Pre-Tax
-469.09%Net

Valuation

-0.10P/E
-0.31P/B
0.47EV/Sales
-1.09EV/EBITDA
-0.23P/FCF

Growth (CAGR)

-1.26%Rev 3Yr
4.17%Rev 5Yr
N/AOp Inc 3Yr
N/AOp Inc 5Yr
N/ANet Inc 3Yr
N/ANet Inc 5Yr

Returns

-117.71%ROA
1068.25%ROE
-117.56%ROIC

Financial Health

$968.00KCash & Cash Equivalents
$56.04MNet Debt
-305.07%Debt/Equity
N/AInterest Cov

Frequently Asked Questions

Jaguar Health Inc. (ticker: JAGX) is a company listed on NASDAQ in the Healthcare sector (Biotechnology). It has approximately 49 employees. Market cap is $5M.

The current price is $2.31 with a P/E ratio of -0.1x and P/B of -0.31x.

ROE is 1068.25% and operating margin is -391.87%. Annual revenue is $12M.

Alpha Lenz
Singapore
Treasurer Pte Ltd | License: 202346277E
9 Straits View Marina One West Tower #05-07 Singapore 018937
contact@treasurer.co.kr
©2026 Treasurer Pte Ltd. All rights reserved.
Jaguar Health Inc. (JAGX) Stock Forecast 2026 $2.31 — Price, Financials & Analyst Targets | Alpha Lenz